Pulmonary function in adult survivors of severe acute lung injury treated with inhaled nitric oxide
- PMID: 9563856
- DOI: 10.1111/j.1399-6576.1998.tb05131.x
Pulmonary function in adult survivors of severe acute lung injury treated with inhaled nitric oxide
Abstract
Background: Following an episode of acute respiratory distress syndrome (ARDS), some degree of measurable pulmonary impairment may be anticipated. ARDS is thought to be the more severe form of acute lung injury (ALI) and a recently proposed addition to conventional therapy in ALI/ARDS is inhaled nitric oxide (INO). We carried out a non-randomised follow-up study with pulmonary function tests on survivors of severe ALI/ARDS treated with INO.
Methods: Sixteen previously healthy pulmonary patients, survivors of severe ALI/ARDS, were evaluated with pulmonary function tests >8 months after the acute event. The tests included static and dynamic spirometry, diffusion capacity for carbon monoxide (DLCO), blood gas analysis and evaluation of a chest radiograph.
Results: The most common abnormality seen was a low DLCO in 69% of the patients. Abnormally low values were seen in forced vital capacity in 31%, in forced expiratory volume in 1 s in 13%, and in residual volume and total lung capacity in 6%. Blood gas data were within normal limits in 15/16 patients. All chest radiographs showed resolution of the interstitial and alveolar changes present during the acute event.
Conclusion: In this non-randomised follow-up study we conclude that a degree of measurable pulmonary impairment after INO treatment in severe ALI/ARDS was common, but did not differ markedly from other published studies on pulmonary function in similar patient material. No late unexpected major abnormalities due to the inhaled nitric oxide treatment could be identified in these survivors.
Similar articles
-
Association between inhaled nitric oxide treatment and long-term pulmonary function in survivors of acute respiratory distress syndrome.Crit Care. 2012 Dec 12;16(2):R36. doi: 10.1186/cc11215. Crit Care. 2012. PMID: 22386043 Free PMC article. Clinical Trial.
-
[Computed tomographic criteria as expected effect to inhaled nitric oxide in patients with severe acute respiratory distress syndrome].Rofo. 2005 Jun;177(6):805-11. doi: 10.1055/s-2005-858190. Rofo. 2005. PMID: 15902629 German.
-
Response to inhaled nitric oxide in acute lung injury depends on distribution of pulmonary blood flow prior to its administration.Am J Respir Crit Care Med. 1999 Feb;159(2):563-70. doi: 10.1164/ajrccm.159.2.9806133. Am J Respir Crit Care Med. 1999. PMID: 9927374
-
[Inhaled nitric oxide: one modality in the treatment of ARDS].Gac Med Mex. 1999 Jul-Aug;135(4):417-21. Gac Med Mex. 1999. PMID: 10491897 Review. Spanish.
-
A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndrome.Pharmacotherapy. 2014 Mar;34(3):279-90. doi: 10.1002/phar.1365. Pharmacotherapy. 2014. PMID: 24734313 Review.
Cited by
-
Hospital admission for COVID-19 pneumonitis - long-term impairment in quality of life and lung function.Eur Clin Respir J. 2022 Jan 7;9(1):2024735. doi: 10.1080/20018525.2021.2024735. eCollection 2022. Eur Clin Respir J. 2022. PMID: 35024101 Free PMC article.
-
Inhaled nitric oxide applications in paediatric practice.Images Paediatr Cardiol. 2002 Jan;4(1):4-29. Images Paediatr Cardiol. 2002. PMID: 22368608 Free PMC article.
-
1-year pulmonary function and health status in survivors of severe acute respiratory syndrome.Chest. 2005 Sep;128(3):1393-400. doi: 10.1378/chest.128.3.1393. Chest. 2005. PMID: 16162734 Free PMC article.
-
Pathophysiology of pulmonary hypertension in acute lung injury.Am J Physiol Lung Cell Mol Physiol. 2012 May 1;302(9):L803-15. doi: 10.1152/ajplung.00355.2011. Epub 2012 Jan 13. Am J Physiol Lung Cell Mol Physiol. 2012. PMID: 22246001 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources